Feno predicts short term risk of moderate/severe copd exacerbations

被引：1
|
作者：
Quesada Quesada, A. [1 ]
Ramirez Rodriguez, G. [1 ]
Menendez Lobo, A. [1 ]
Romero Linares, A. [1 ]
Romero Palacios, P. J. [2 ]
Alcazar Navarrete, B. [1 ]
机构：
[1] Hosp Univ Virgen de las Nieves, Granada, Spain
[2] Univ Granada, Dept Med, Granada, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2190
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2190
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Budesonide/formoterol in a single inhaler (Symbicort®) reduces severe exacerbations in patients with moderate to severe COPD
    Campbell, LM
    Szafranski, W
    THORAX, 2002, 57
  • [22] Both moderate and severe exacerbations accelerate physical activity decline in COPD patients
    Demeyer, Heleen
    Costilla-Frias, Marcos
    Louvaris, Zafeiris
    Gimeno-Santos, Elena
    Tabberer, Maggie
    Rabinovich, Roberto A.
    de Jong, Corina
    Polkey, Michael I.
    Hopkinson, Nicholas S.
    Karlsson, Niklas
    Serra, Ignasi
    Vogiatzis, Ioannis
    Troosters, Thierry
    Garcia-Aymerich, Judith
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (01)
  • [23] Both Moderate And Severe Exacerbations Accelerate Physical Activity Decline In COPD Patients
    Demeyer, H.
    Costilla-Frias, M.
    Louvaris, Z.
    Gimeno-Santos, E.
    Tabberer, M.
    Ivanoff, N.
    Rabinovich, R.
    Karlsson, N.
    Serra, I.
    Vogiatzis, I.
    Troosters, T.
    Garcia-Aymerich, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] COMPARISON OF OUTPATIENT AND INPATIENT COSTS OF MODERATE AND SEVERE EXACERBATIONS OF COPD IN POLAND IN 2007
    Jahnz-Rozyk, K.
    Targowski, T.
    Mierzejewska, M. J.
    From, S.
    VALUE IN HEALTH, 2008, 11 (06) : A451 - A451
  • [25] Deep Residual Convolutional Network Predicts Future Severe Exacerbations of COPD in SPIROMICS
    Awan, H.
    Chaudhary, M.
    Gerard, S. E.
    Comellas, A. P.
    Hoffman, E. A.
    Barjaktarevic, I.
    Bhatt, S. P.
    Cooper, C. B.
    Criner, G. J.
    Hansel, N. N.
    Krishnan, J. A.
    Ortega, V. E.
    Paine, R.
    Schroeder, J. D.
    Reinhardt, J. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] Impact of erdosteine on exacerbations in moderate COPD
    Calverley, P. M. A.
    Papi, A.
    Page, C.
    Rogliani, P.
    Dal Negro, R.
    Cazzola, M.
    Cicero, A.
    Wedzicha, W.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [27] Predictors of short-term LAMA ineffectiveness in treatment naive patients with moderate to severe COPD
    Fijacko, Vladimir
    Labor, Marina
    Fijacko, Mirjana
    Skrinjaric-Cincar, Sanda
    Labor, Slavica
    Dubravcic, Iva Dumbovic
    Bacun, Tatjana
    Vcev, Aleksandar
    Popovic-Grle, Sanja
    Plavec, Davor
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 (7-8) : 247 - 258
  • [28] Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?
    Annesi-Maesano, Isabella
    Cecchi, Lorenzo
    Biagioni, Benedetta
    Chung, Kian Fan
    Clot, Bernard
    Collaud Coen, Martine
    Amato, Gennaro D.
    Damialis, Athanasios
    Dominguez-Ortega, Javier
    Galan, Carmen
    Gilles, Stefanie
    Holgate, Stephen
    Jeebhay, Mohamed
    Kazadzis, Stelios
    Papadopoulos, Nikolaos G.
    Quirce, Santiago
    Sastre, Joaquin
    Tummon, Fiona
    Traidl-Hoffmann, Claudia
    Walusiak-Skorupa, Jolanta
    Alonso-Coello, Pablo
    Canelo-Aybar, Carlos
    Cantero-Fortiz, Yahveth
    Rigau, David
    Salazar, Josefina
    Verdugo-Paiva, Francisca
    Jutel, Marek
    Akdis, Cezmi A.
    Agache, Ioana
    ALLERGY, 2023, 78 (08) : 2121 - 2147
  • [29] Aclidinium Bromide Treatment in Patients Receiving Beta-Blockers: Effects on MACE, Moderate/Severe COPD Exacerbations, and Lung Function in Patients with Moderate-to-Very Severe COPD and Cardiovascular Risk Factors (ASCENT-COPD)
    Chapman, K. R.
    Wise, R. A.
    Scirica, B. M.
    Bhatt, D. L.
    Daoud, S. Z.
    Lythgoe, D.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [30] Tiotropium reduced exacerbations more than salmeterol in moderate-to-very severe COPD
    Wark, Peter
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (02)
12345